Heraeus acquires exclusive license for antimicrobial shield

  • Date 30 Nov 2020

In the middle of the Corona pandemic, Heraeus contributes to the combat against viruses and germs with an environmentally friendly, completely new technology. The Hanau-based technology group has acquired the exclusive license for AGXX particles, a catalytically driven antimicrobial protective shield, from the Berlin start-up Largentec.

Heraeus will now bring the full potential of the technology to market maturity for various fields of application. "We are currently working at full speed to introduce AGXX particles into materials and products that are susceptible to colonisation by germs. AGXX can thus also make a contribution to contain COVID-19," says Martin Danz, Head of Business Development at Heraeus Precious Metals.

AGXX particles have an excellent antimicrobial effect, which has already been successfully tested against more than 130 microorganisms, including Sars-CoV-2 viruses. In addition, AGXX offers many other advantages compared to conventional antimicrobial solutions: The AGXX particles contain neither pharmaceuticals nor harmful biocides and are therefore - unlike many other antimicrobial technologies - not harmful to humans, animals or the environment. Conventional antimicrobial substances lose their effect relatively quickly. The consequences are a high workload and maintenance costs for follow-up measures.

Read more

Join an ambitious, supportive community of world-class scientists, engineers and entrepreneurs

Read more